Clinical breast cancer

Keyphrases

Publications

volume 24, number 6, 2024

Yixuan Hu, Yinxing Zhu, Junfeng Shi, Xiaowei Wei, Cuiju Tang, Xiaoxiang Guan, Wenwen Zhang
Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer. Clinical breast cancer 24 (6) (2024)
Jia-Xin Huang, Yi-Jie Chen, Xue-Yan Wang, Jia-Hui Huang, Ke-Hong Gan, Li-Na Tang, Xiao-Qing Pei
Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer. Clinical breast cancer 24 (6) (2024)
Fu-An Yang, Pei-Jyuan Wu, Yi-Tien Su, Po-Chin Strong, Yi-Ching Chu, Chao-Chun Huang
Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical breast cancer 24 (6) (2024)
Romain Varnier, Aurélie Moskal, Céline Bodelet, Julien Péron, Marion Lamort-Bouché, Jean-Baptiste Fassier, Alexandra L Dima, Marie Viprey
Implementing Indicators and Trajectories of Return to Work After Breast Cancer Diagnosis: A Mixed-Methods Study Using the French National Healthcare Insurance Database and Stakeholder Consultation. Clinical breast cancer 24 (6) (2024)
Weining Pan, Hui Cheng, Juan Zhang, Zijie Yang, Mengbo Lin
The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review. Clinical breast cancer 24 (6) (2024)
George S Corpuz, Dylan K Kim, Isaac E Kim, Christine H Rohde
Existing Psychiatric Diagnoses Among Breast Cancer Patients Interact with Outcomes After Autologous and Implant-Based Bilateral Breast Reconstruction: A Propensity Score Matched Analysis. Clinical breast cancer 24 (6) (2024)
Wei Wen, Yuehua Li, Xi Cao, Yanyan Li, Ziyi Liu, Zhuoqi Tang, Liming Xie, Rongfang He
Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer. Clinical breast cancer 24 (6) (2024)
Samir Mitri, Estefania Roldan-Vasquez, Rene Flores, Jaime Pardo, Giulia Borgonovo, Roger B Davis ScD, Ted A James
Axillary Management Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Clinical breast cancer 24 (6) (2024)
Matheus Wohlfahrt Baumgarten, Iuri Martin Goemann, Rafael Selbach Scheffel, Ana Luiza Maia
Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation. Clinical breast cancer 24 (6) (2024)
Ahuva Grubstein, Marva Dahan, Wael Jomar, Tal Friehmann, Shlomit Tamir, Tzippy Shochat, Eli Atar, Tanir M Allweis
Screening Mammography for Males With Elevated Breast Cancer Risk, Mutation Carriers, and Gynecomastia. Clinical breast cancer 24 (6) (2024)
Fernanda Mesa-Chavez, Yanin Chavarri-Guerra, Adara Valeria López-Covarrubias, Andrea Elena Mayette-Villanueva, Sandy Ruiz-Cruz, Christopher Jesús Del Río-Martínez, Carmen Guadalupe Bermudez-Barrientos, Abigail Samayoa-Mateos, Alejandra Gabriela Manzanares-Castellanos, Brizio Moreno-Jaime, David Vega-Morales, Juan Alberto Tenorio-Torres, Cynthia Villarreal-Garza
Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors. Clinical breast cancer 24 (6) (2024)
Jia-Xin Huang, Yi-Jie Chen, Xue-Yan Wang, Jia-Hui Huang, Ke-Hong Gan, Li-Na Tang, Xiao-Qing Pei
Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer. Clinical breast cancer 24 (6) (2024)
Çağdaş Rıza Açar, Sebnem Orguc
Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging. Clinical breast cancer 24 (6) (2024)
Weining Pan, Hui Cheng, Juan Zhang, Zijie Yang, Mengbo Lin
The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review. Clinical breast cancer 24 (6) (2024)
Ahuva Grubstein, Marva Dahan, Wael Jomar, Tal Friehmann, Shlomit Tamir, Tzippy Shochat, Eli Atar, Tanir M Allweis
Screening Mammography for Males With Elevated Breast Cancer Risk, Mutation Carriers, and Gynecomastia. Clinical breast cancer 24 (6) (2024)
Yixuan Hu, Yinxing Zhu, Junfeng Shi, Xiaowei Wei, Cuiju Tang, Xiaoxiang Guan, Wenwen Zhang
Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer. Clinical breast cancer 24 (6) (2024)
Jia-Xin Huang, Yi-Jie Chen, Xue-Yan Wang, Jia-Hui Huang, Ke-Hong Gan, Li-Na Tang, Xiao-Qing Pei
Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer. Clinical breast cancer 24 (6) (2024)
Kari M Rosenkranz, Judy C Boughey
Locoregional Management of Multiple Ipsilateral Breast Cancers: A Review. Clinical breast cancer 24 (6) (2024)
Chia Yew Kong, Jacob Williams, Niroshini Hemadasa, Dermot Murphy, Maria Bews-Hair
The Introduction of Magtrace® Lymphatic Tracer for Axillary Sentinel Node Biopsy for Breast Cancer in a Rural Scottish District General Hospital: Initial Experience, Perspectives, Outcomes and Learning Curves. Clinical breast cancer 24 (6) (2024)
Romain Varnier, Aurélie Moskal, Céline Bodelet, Julien Péron, Marion Lamort-Bouché, Jean-Baptiste Fassier, Alexandra L Dima, Marie Viprey
Implementing Indicators and Trajectories of Return to Work After Breast Cancer Diagnosis: A Mixed-Methods Study Using the French National Healthcare Insurance Database and Stakeholder Consultation. Clinical breast cancer 24 (6) (2024)
Fernanda Mesa-Chavez, Yanin Chavarri-Guerra, Adara Valeria López-Covarrubias, Andrea Elena Mayette-Villanueva, Sandy Ruiz-Cruz, Christopher Jesús Del Río-Martínez, Carmen Guadalupe Bermudez-Barrientos, Abigail Samayoa-Mateos, Alejandra Gabriela Manzanares-Castellanos, Brizio Moreno-Jaime, David Vega-Morales, Juan Alberto Tenorio-Torres, Cynthia Villarreal-Garza
Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors. Clinical breast cancer 24 (6) (2024)
Chia Yew Kong, Jacob Williams, Niroshini Hemadasa, Dermot Murphy, Maria Bews-Hair
The Introduction of Magtrace® Lymphatic Tracer for Axillary Sentinel Node Biopsy for Breast Cancer in a Rural Scottish District General Hospital: Initial Experience, Perspectives, Outcomes and Learning Curves. Clinical breast cancer 24 (6) (2024)
Gary Ko, Gayathri Naganathan, Emma Reel, Jordan Cleland, Andrea Covelli, Frances C Wright, Tulin D Cil
The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons' Perspectives. Clinical breast cancer 24 (6) (2024)
Yixuan Hu, Yinxing Zhu, Junfeng Shi, Xiaowei Wei, Cuiju Tang, Xiaoxiang Guan, Wenwen Zhang
Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer. Clinical breast cancer 24 (6) (2024)
Manqi Zhang, Hailing Zha, Jiazhen Pan, Xiaoan Liu, Min Zong, Liwen Du, Yu Du
Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer. Clinical breast cancer 24 (6) (2024)
Gary Ko, Gayathri Naganathan, Emma Reel, Jordan Cleland, Andrea Covelli, Frances C Wright, Tulin D Cil
The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons' Perspectives. Clinical breast cancer 24 (6) (2024)
Samir Mitri, Estefania Roldan-Vasquez, Rene Flores, Jaime Pardo, Giulia Borgonovo, Roger B Davis ScD, Ted A James
Axillary Management Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Clinical breast cancer 24 (6) (2024)
Gordon R Daly, Gavin P Dowling, Eman Hamza, Ma'en AlRawashdeh, Aisling Hegarty, Tarnum Naz, Jason McGrath, Sindhuja Naidoo, Eithne Downey, Abeeda Butt, Colm Power, Arnold D K Hill
Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer ≥ 70 Years Old? Clinical breast cancer 24 (6) (2024)
Jie Huang, Shujuan Sun, Qiaorui Tan, Fangchao Zheng, Dongdong Zhou, Xiaochu Man, Yu Hu, Wenhuan Li, Lihua Song, Baoxuan Zhang, Liang Xu, Xinzhao Wang, Xuemei Xie, Huihui Li
Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study. Clinical breast cancer 24 (6) (2024)
Fu-An Yang, Pei-Jyuan Wu, Yi-Tien Su, Po-Chin Strong, Yi-Ching Chu, Chao-Chun Huang
Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical breast cancer 24 (6) (2024)
Chia Yew Kong, Jacob Williams, Niroshini Hemadasa, Dermot Murphy, Maria Bews-Hair
The Introduction of Magtrace® Lymphatic Tracer for Axillary Sentinel Node Biopsy for Breast Cancer in a Rural Scottish District General Hospital: Initial Experience, Perspectives, Outcomes and Learning Curves. Clinical breast cancer 24 (6) (2024)
Matheus Wohlfahrt Baumgarten, Iuri Martin Goemann, Rafael Selbach Scheffel, Ana Luiza Maia
Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation. Clinical breast cancer 24 (6) (2024)
Manqi Zhang, Hailing Zha, Jiazhen Pan, Xiaoan Liu, Min Zong, Liwen Du, Yu Du
Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer. Clinical breast cancer 24 (6) (2024)
Kari M Rosenkranz, Judy C Boughey
Locoregional Management of Multiple Ipsilateral Breast Cancers: A Review. Clinical breast cancer 24 (6) (2024)
George S Corpuz, Dylan K Kim, Isaac E Kim, Christine H Rohde
Existing Psychiatric Diagnoses Among Breast Cancer Patients Interact with Outcomes After Autologous and Implant-Based Bilateral Breast Reconstruction: A Propensity Score Matched Analysis. Clinical breast cancer 24 (6) (2024)
Manqi Zhang, Hailing Zha, Jiazhen Pan, Xiaoan Liu, Min Zong, Liwen Du, Yu Du
Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer. Clinical breast cancer 24 (6) (2024)
Wei Wen, Yuehua Li, Xi Cao, Yanyan Li, Ziyi Liu, Zhuoqi Tang, Liming Xie, Rongfang He
Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer. Clinical breast cancer 24 (6) (2024)
Weining Pan, Hui Cheng, Juan Zhang, Zijie Yang, Mengbo Lin
The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review. Clinical breast cancer 24 (6) (2024)
Julie Malloizel-Delaunay, Ariane Weyl, Clara Brusq, Benoît Chaput, Barbara Garmy-Susini, Vanina Bongard, Charlotte Vaysse
New Strategy for Breast Cancer Related Lymphedema Treatment by Endermology: ELOCS Phase II Randomized Controlled Trial. Clinical breast cancer 24 (6) (2024)
Tuğba Önder, Öztürk Ateş, İrem Öner, Cengiz Karaçin
Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors. Clinical breast cancer 24 (6) (2024)
Julie Malloizel-Delaunay, Ariane Weyl, Clara Brusq, Benoît Chaput, Barbara Garmy-Susini, Vanina Bongard, Charlotte Vaysse
New Strategy for Breast Cancer Related Lymphedema Treatment by Endermology: ELOCS Phase II Randomized Controlled Trial. Clinical breast cancer 24 (6) (2024)
Matheus Wohlfahrt Baumgarten, Iuri Martin Goemann, Rafael Selbach Scheffel, Ana Luiza Maia
Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation. Clinical breast cancer 24 (6) (2024)
Jie Huang, Shujuan Sun, Qiaorui Tan, Fangchao Zheng, Dongdong Zhou, Xiaochu Man, Yu Hu, Wenhuan Li, Lihua Song, Baoxuan Zhang, Liang Xu, Xinzhao Wang, Xuemei Xie, Huihui Li
Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study. Clinical breast cancer 24 (6) (2024)
Çağdaş Rıza Açar, Sebnem Orguc
Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging. Clinical breast cancer 24 (6) (2024)
Romain Varnier, Aurélie Moskal, Céline Bodelet, Julien Péron, Marion Lamort-Bouché, Jean-Baptiste Fassier, Alexandra L Dima, Marie Viprey
Implementing Indicators and Trajectories of Return to Work After Breast Cancer Diagnosis: A Mixed-Methods Study Using the French National Healthcare Insurance Database and Stakeholder Consultation. Clinical breast cancer 24 (6) (2024)
Ahuva Grubstein, Marva Dahan, Wael Jomar, Tal Friehmann, Shlomit Tamir, Tzippy Shochat, Eli Atar, Tanir M Allweis
Screening Mammography for Males With Elevated Breast Cancer Risk, Mutation Carriers, and Gynecomastia. Clinical breast cancer 24 (6) (2024)
Gordon R Daly, Gavin P Dowling, Eman Hamza, Ma'en AlRawashdeh, Aisling Hegarty, Tarnum Naz, Jason McGrath, Sindhuja Naidoo, Eithne Downey, Abeeda Butt, Colm Power, Arnold D K Hill
Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer ≥ 70 Years Old? Clinical breast cancer 24 (6) (2024)
George S Corpuz, Dylan K Kim, Isaac E Kim, Christine H Rohde
Existing Psychiatric Diagnoses Among Breast Cancer Patients Interact with Outcomes After Autologous and Implant-Based Bilateral Breast Reconstruction: A Propensity Score Matched Analysis. Clinical breast cancer 24 (6) (2024)
Wei Wen, Yuehua Li, Xi Cao, Yanyan Li, Ziyi Liu, Zhuoqi Tang, Liming Xie, Rongfang He
Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer. Clinical breast cancer 24 (6) (2024)
Tuğba Önder, Öztürk Ateş, İrem Öner, Cengiz Karaçin
Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors. Clinical breast cancer 24 (6) (2024)